TickerFacts.

Idexx Laboratories Inc (IDXX): Revenue

Annual figures by period end, from SEC filings.

$4.30B
Year ended 2025-12-31
$4.55B
Trailing 12 months to 2026-06-30
+8.5%
3-year compound annual growth
+9.7%
5-year compound annual growth
+10.4%
10-year compound annual growth
2008-12-31: $1.02B2009-12-31: $1.03B2010-12-31: $1.10B2011-12-31: $1.22B2012-12-31: $1.29B2013-12-31: $1.38B2014-12-31: $1.49B2015-12-31: $1.60B2016-12-31: $1.78B2017-12-31: $1.97B2018-12-31: $2.21B2019-12-31: $2.41B2020-12-31: $2.71B2021-12-31: $3.22B2022-12-31: $3.37B2023-12-31: $3.66B2024-12-31: $3.90B2025-12-31: $4.30B$4.30B
2008-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$4.30B+10.4%2026-02-20, From 2025-01-01
2024-12-31$3.90B+6.5%2026-02-20, From 2024-01-01
2023-12-31$3.66B+8.7%2026-02-20, From 2023-01-01
2022-12-31$3.37B+4.7%2025-02-21, From 2022-01-01
2021-12-31$3.22B+18.8%2024-02-22, From 2021-01-01
2020-12-31$2.71B+12.5%2023-02-16, From 2020-01-01
2019-12-31$2.41B+8.8%2022-02-16, From 2019-01-01
2018-12-31$2.21B+12.4%2021-02-12, From 2018-01-01
2017-12-31$1.97B+10.9%2020-02-14, From 2017-01-01
2016-12-31$1.78B+10.8%2019-02-15, From 2016-01-01
2015-12-31$1.60B+7.8%2018-02-16, From 2015-01-01
2014-12-31$1.49B+7.9%2017-02-17, From 2014-01-01
2013-12-31$1.38B+6.5%2016-02-17, From 2013-01-01
2012-12-31$1.29B+6.1%2015-02-17, From 2012-01-01
2011-12-31$1.22B+10.4%2014-02-18, From 2011-01-01
2010-12-31$1.10B+7.0%2013-02-19, From 2010-01-01
2009-12-31$1.03B+0.7%2012-02-17, From 2009-01-01
2008-12-31$1.02Bn/a2011-02-22, From 2008-01-01

Revenue at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Idexx Laboratories Inc (IDXX)2025-12-31$4.30B+10.4%
QuidelOrtho Corp (QDEL)2025-12-28$2.73B-1.9%
Lantheus Holdings, Inc. (LNTH)2025-12-31$1.54B+0.5%
Neogen Corp (NEOG)2026-05-31$870.40M-2.7%
Myriad Genetics Inc (MYGN)2025-12-31$824.50M-1.6%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$67.67M+16.9%
Alpha Teknova, Inc. (TKNO)2025-12-31$40.52M+7.4%
Immucell Corp (ICCC)2025-12-31$27.64M+4.3%
Aspira Women's Health Inc. (AWHL)2025-12-31$9.22M+0.4%

Compare IDXX, QDEL, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗